Cella Therapeutics

Cello Therapeutics, Inc. (Cello) is a leading biotechnology company focused on developing novel nanoparticle delivery platforms for cancer treatment. Our nanoparticles consist of three main components — chemotherapeutic or immune-modulating agents, biocompatible polymers, and natural cell membranes. The goal is to treat all types of cancer using a single delivery platform. In vitro and in vivo studies have shown that these biomimetic nanoparticles significantly enhance the performance of chemotherapy and immunotherapy. In repeated in vivo studies, one of our immunotherapy nanoparticle formulations has increased cancer survival rates in mouse cancer models to 85-100%. Cello Therapeutics, Inc. was founded in 2016 in San Diego, California, and has been committed to saving patients' lives.